8.88
4.23%
0.36
시간 외 거래:
8.98
0.10
+1.13%
Engene Holdings Inc 주식(ENGN)의 최신 뉴스
enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference - StockTitan
Forbion growth opportunities fund acquires $4.99m in Engene Holdings shares By Investing.com - Investing.com South Africa
Forbion growth opportunities fund acquires $4.99m in Engene Holdings shares - Investing.com Australia
FY2024 EPS Estimates for enGene Boosted by Leerink Partnrs - MarketBeat
EnGene Announces $60 Million Private Placement Financing - Marketscreener.com
enGene Holdings Inc. (NASDAQ:ENGN) Sees Significant Growth in Short Interest - MarketBeat
enGene secures $60 million in private placement By Investing.com - Investing.com Canada
enGene Announces $60 Million Private Placement Financing - citybiz
Why enGene Holdings Stock Is Trading Higher - Benzinga
enGene secures $60 million in private placement - Investing.com
EnGene Holdings Shares Rise After $60M Private Placement - MarketWatch
enGene Holdings Secures $60 Million for Genetic Medicines - TipRanks
EnGene Holdings Inc. announced that it expects to receive CAD 60.148968 million in funding from a group of investors - Marketscreener.com
EnGene Holdings Inc. announced that it expects to receive $60.148968 million in funding from a group of investors - Marketscreener.com
enGene Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer - citybiz
enGene Holdings Announces Key Executive Appointments - TipRanks
EnGene Holdings Inc. Announces Executive Changes - Marketscreener.com
enGene CTO Anthony Cheung transitions to CSO, Joan Connolly to succeed - TipRanks
enGene Holdings Inc. (NASDAQ:ENGN) Major Shareholder Purchases $19,717.50 in Stock - MarketBeat
Forbion growth opportunities fund increases stake in Engene Holdings with $3 million purchase - Investing.com Australia
enGene Holdings Inc. (NASDAQ:ENGN) Receives $33.67 Average PT from Analysts - MarketBeat
Long Term Trading Analysis for (ENGN) - Stock Traders Daily
Short Interest in enGene Holdings Inc. (NASDAQ:ENGN) Rises By 130.0% - MarketBeat
(ENGN) Investment Report - Stock Traders Daily
Insider Buys Additional US$57k In enGene Holdings Stock - Yahoo Finance
This trade activity should not be overlooked: enGene Holdings Inc (ENGN) - SETE News
An Analysis of enGene Holdings Inc (ENGN)’s Potential Price Growth - Knox Daily
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - StockTitan
The Psychology of enGene Holdings Inc Inc. (ENGN) Price Performance: Understanding Market Sentiment - The InvestChronicle
enGene Holdings Inc. (NASDAQ:ENGN) CEO Ronald Harold Wilfred Cooper Buys 10,000 Shares - MarketBeat
engene CEO buys $57k in company shares - Investing.com
engene CEO buys $57k in company shares By Investing.com - Investing.com Canada
Perceptive Advisors LLC Trims Position in enGene Holdings Inc. (NASDAQ:ENGN) - MarketBeat
enGene Holdings Inc. (NASDAQ:ENGN) Sees Large Increase in Short Interest - MarketBeat
Engene shares hold as Oppenheimer stands by $30 target - Investing.com South Africa
Morgan Stanley maintains price target on Engene Holdings shares By Investing.com - Investing.com South Africa
Morgan Stanley maintains price target on Engene Holdings shares - Investing.com
EnGene Holdings Touches 52-Week Low After Drug Study Update - MarketWatch
The Future of enGene Holdings Inc: Analyzing ENGN - The InvestChronicle
enGene price target lowered to $17 from $26 at Leerink - TipRanks
SEC Form 424B3 filed by enGene Holdings Inc. - Quantisnow
enGene Holdings Excels in Bladder Cancer Treatment Trial - TipRanks
Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort - Business Wire
(ENGN) Technical Data - Stock Traders Daily
enGene Holdings Inc. (NASDAQ:ENGNW) Short Interest Up 7,700.0% in September - Defense World
Engene stock poised for upside as key bladder cancer trial results nearOppenheimer - Investing.com India
자본화:
|
볼륨(24시간):